Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts
Elli Papaemmanuil, Mario Cazzola, Jacqueline Boultwood, et al.
New England Journal of Medicine (2011) Vol. 365, Iss. 15, pp. 1384-1395
Open Access | Times Cited: 1162

Showing 1-25 of 1162 citing articles:

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, et al.
Blood (2016) Vol. 127, Iss. 20, pp. 2391-2405
Open Access | Times Cited: 9112
Cancer Genome Landscapes
Bert Vogelstein, Nickolas Papadopoulos, Victor E. Velculescu, et al.
Science (2013) Vol. 339, Iss. 6127, pp. 1546-1558
Open Access | Times Cited: 7295
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, et al.
New England Journal of Medicine (2014) Vol. 371, Iss. 26, pp. 2488-2498
Open Access | Times Cited: 4106
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese, Anna K. Kähler, Robert E. Handsaker, et al.
New England Journal of Medicine (2014) Vol. 371, Iss. 26, pp. 2477-2487
Open Access | Times Cited: 3089
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg, Heinz Tuechler, Julie Schanz, et al.
Blood (2012) Vol. 120, Iss. 12, pp. 2454-2465
Open Access | Times Cited: 2861
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma, Rafael Bejar, Siddhartha Jaiswal, et al.
Blood (2015) Vol. 126, Iss. 1, pp. 9-16
Open Access | Times Cited: 1720
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati, et al.
Blood (2013) Vol. 122, Iss. 22, pp. 3616-3627
Open Access | Times Cited: 1711
SomaticCALRMutations in Myeloproliferative Neoplasms with NonmutatedJAK2
Jyoti Nangalia, Charles Massie, E. Joanna Baxter, et al.
New England Journal of Medicine (2013) Vol. 369, Iss. 25, pp. 2391-2405
Open Access | Times Cited: 1647
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
William J. Gradishar, Benjamin O. Anderson, Ronald Balassanian, et al.
Journal of the National Comprehensive Cancer Network (2018) Vol. 16, Iss. 3, pp. 310-320
Open Access | Times Cited: 1597
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
Marilyn M. Li, Michael Datto, Eric J. Duncavage, et al.
Journal of Molecular Diagnostics (2016) Vol. 19, Iss. 1, pp. 4-23
Open Access | Times Cited: 1586
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
Torsten Haferlach, Yasunobu Nagata, Vera Grossmann, et al.
Leukemia (2013) Vol. 28, Iss. 2, pp. 241-247
Open Access | Times Cited: 1420
The Life History of 21 Breast Cancers
Serena Nik‐Zainal, Peter Van Loo, David C. Wedge, et al.
Cell (2012) Vol. 149, Iss. 5, pp. 994-1007
Open Access | Times Cited: 1402
Lessons from the Cancer Genome
Levi A. Garraway, Eric S. Lander
Cell (2013) Vol. 153, Iss. 1, pp. 17-37
Open Access | Times Cited: 1258
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
Elza C. de Bruin, Nicholas McGranahan, Richard Mitter, et al.
Science (2014) Vol. 346, Iss. 6206, pp. 251-256
Open Access | Times Cited: 1051
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
Vı́ctor Quesada, Laura Peña Conde, Neus Villamor, et al.
Nature Genetics (2011) Vol. 44, Iss. 1, pp. 47-52
Closed Access | Times Cited: 983
Whole-genome analysis informs breast cancer response to aromatase inhibition
Matthew J. Ellis, Li Ding, Dong Shen, et al.
Nature (2012) Vol. 486, Iss. 7403, pp. 353-360
Open Access | Times Cited: 973
RNA in cancer
Gregory J. Goodall, Vihandha O. Wickramasinghe
Nature reviews. Cancer (2020) Vol. 21, Iss. 1, pp. 22-36
Closed Access | Times Cited: 837
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Niccolò Bolli, Hervé Avet‐Loiseau, David C. Wedge, et al.
Nature Communications (2014) Vol. 5, Iss. 1
Open Access | Times Cited: 823
The long tail of oncogenic drivers in prostate cancer
Joshua Armenia, Stephanie A. Wankowicz, David Liu, et al.
Nature Genetics (2018) Vol. 50, Iss. 5, pp. 645-651
Open Access | Times Cited: 758
SomaticSTAT3Mutations in Large Granular Lymphocytic Leukemia
Hanna Koskela, Samuli Eldfors, Pekka Ellonen, et al.
New England Journal of Medicine (2012) Vol. 366, Iss. 20, pp. 1905-1913
Open Access | Times Cited: 732
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
Luca Malcovati, Eva Hellström‐Lindberg, David Bowen, et al.
Blood (2013) Vol. 122, Iss. 17, pp. 2943-2964
Open Access | Times Cited: 635
Epigenomic Profiling of Young and Aged HSCs Reveals Concerted Changes during Aging that Reinforce Self-Renewal
Deqiang Sun, Min Luo, Mira Jeong, et al.
Cell stem cell (2014) Vol. 14, Iss. 5, pp. 673-688
Open Access | Times Cited: 604
RNA splicing factors as oncoproteins and tumour suppressors
Heidi Dvinge, Eun Hee Kim, Omar Abdel‐Wahab, et al.
Nature reviews. Cancer (2016) Vol. 16, Iss. 7, pp. 413-430
Open Access | Times Cited: 603
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Adam S. Sperling, Christopher J. Gibson, Benjamin L. Ebert
Nature reviews. Cancer (2016) Vol. 17, Iss. 1, pp. 5-19
Open Access | Times Cited: 603
Roles and mechanisms of alternative splicing in cancer — implications for care
Sophie Bonnal, Irene López‐Oreja, Juan Valcárcel
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 8, pp. 457-474
Closed Access | Times Cited: 565
Page 1 - Next Page

Scroll to top